All Insights Articles

We talked to U.S. Army Colonel Rich Morales ’99 about the complexity of integrity and its roles in leadership and learning.

A study co-authored by Yale SOM researchers Florian Ederer and Song Ma suggests that “killer acquisitions” by pharmaceutical companies are potentially limiting the number of new treatments available.

Yale SOM’s Jeffrey Sonnenfeld writes that CEO Bob Iger did the right thing by swiftly cancelling the highly rated show.

Nonprofits compete too. Could technology offer a means to improve performance, innovate, and deliver on mission?

A change to European privacy rules has unleashed a flood of emails about updated privacy policies to customers all over the world. We asked Yale SOM’s David Bach why.

Neal Keny-Guyer ’82, the CEO of Mercy Corps, on negotiating with extremist groups to provide humanitarian relief in conflict zones.

There is increasing evidence that isolation has a powerful negative effect on health and productivity. We asked Yale SOM’s Marissa King, an expert on social networks, how we can reinforce the connections that help sustain us.

A statistical tool that predicts when patients with advanced cancer are likely to die could help promote patient welfare by transferring more people from aggressive interventions to hospice care.

Political polarization is growing and long-established norms that used to serve as landmarks are fading. Experts discuss navigating the challenges of working in and engaging with an administration that has torn up the playbook.

Jeffrey Sonnenfeld says the CEOs of AT&T and Novartis were right to respond swiftly and directly to their companies’ connection to the scandal around Michael Cohen.